THC Biomed INTL (THCBF) Ratios
THC Biomed INTL Ratios
THCBF's free cash flow for Q3 2023 was $38.56K. For the 2023 fiscal year, THCBF's free cash flow was decreased by $-352.00 and operating cash flow was $38.91K. See a summary of the company’s cash flow.
| Ratios | Oct 22 | Oct 21 | Oct 20 | Jul 19 | Jul 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.63 | 0.72 | 1.44 | 1.59 | 5.00 |
| Quick Ratio | 0.22 | 0.18 | 0.23 | 0.53 | 4.29 |
| Cash Ratio | 0.07 | 0.02 | 0.13 | 0.30 | 1.23 |
| Solvency Ratio | -0.27 | -0.71 | 0.12 | -2.63 | -5.41 |
| Operating Cash Flow Ratio | -0.27 | -0.17 | 0.02 | -0.57 | -1.49 |
| Short-Term Operating Cash Flow Coverage | -2.11 | -0.81 | 0.09 | -0.86 | -2.47 |
| Net Current Asset Value | $ -3.52M | $ -3.34M | $ 1.14M | $ 614.26K | $ 5.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.18 | 0.13 | 0.19 | 0.11 |
| Debt-to-Equity Ratio | 0.28 | 0.32 | 0.19 | 0.26 | 0.13 |
| Debt-to-Capital Ratio | 0.22 | 0.24 | 0.16 | 0.21 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.14 | 0.07 | 0.09 | 0.05 |
| Financial Leverage Ratio | 2.13 | 1.78 | 1.46 | 1.34 | 1.19 |
| Debt Service Coverage Ratio | -1.18 | -2.92 | 0.73 | -5.28 | -2.11 |
| Interest Coverage Ratio | -5.41 | -14.07 | 0.57 | -48.53 | -15.19 |
| Debt to Market Cap | 0.19 | 0.17 | 0.08 | 0.14 | 0.01 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
| Net Debt to EBITDA | -0.90 | -0.60 | 1.68 | -0.21 | 0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | -42.03% | -84.10% | 77.64% | 100.86% | 50.49% |
| EBIT Margin | -104.69% | -157.31% | 4.77% | -845.97% | -1329.26% |
| EBITDA Margin | -66.79% | -131.35% | 29.05% | -805.38% | -260.21% |
| Operating Profit Margin | -110.62% | -157.25% | 4.91% | -318.44% | -260.49% |
| Pretax Profit Margin | -125.15% | -168.49% | -3.87% | -852.53% | -1346.42% |
| Net Profit Margin | -125.15% | -168.49% | -3.87% | -852.53% | -1346.42% |
| Continuous Operations Profit Margin | -125.15% | -168.49% | -3.87% | -852.53% | -1346.42% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 113.14% | 107.14% | -78.72% | 267.72% | 516.87% |
| Return on Assets (ROA) | -20.79% | -36.55% | -0.74% | -70.32% | -86.04% |
| Return on Equity (ROE) | -44.22% | -65.00% | -1.09% | -94.39% | -102.00% |
| Return on Capital Employed (ROCE) | -34.29% | -51.94% | 1.27% | -32.12% | -18.76% |
| Return on Invested Capital (ROIC) | -30.50% | -46.11% | 1.16% | -28.00% | -13.18% |
| Return on Tangible Assets | -20.79% | -36.55% | -0.74% | -70.34% | -86.14% |
| Earnings Yield | -33.40% | -38.21% | -0.51% | -51.45% | -10.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.56 | 5.68 | 34.51 | 4.08 | 17.22 |
| Payables Turnover | 4.06 | 5.42 | 0.70 | -0.01 | 0.75 |
| Inventory Turnover | 1.56 | 2.16 | 0.14 | -0.00 | 0.39 |
| Fixed Asset Turnover | 0.24 | 0.29 | 0.30 | 0.12 | 0.15 |
| Asset Turnover | 0.17 | 0.22 | 0.19 | 0.08 | 0.06 |
| Working Capital Turnover Ratio | -1.15 | 9.77 | 1.90 | 0.35 | 0.70 |
| Cash Conversion Cycle | 209.06 | 166.02 | 2121.54 | -72701.79 | 466.88 |
| Days of Sales Outstanding | 65.62 | 64.22 | 10.58 | 89.47 | 21.19 |
| Days of Inventory Outstanding | 233.26 | 169.16 | 2630.02 | -99245.05 | 933.63 |
| Days of Payables Outstanding | 89.83 | 67.37 | 519.05 | -26453.78 | 487.95 |
| Operating Cycle | 298.89 | 233.38 | 2640.60 | -99155.58 | 954.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | 0.00 | -0.01 | -0.02 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.07 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -11.59 | -2.80 | 0.08 | -0.26 | -0.47 |
| Capital Expenditure Coverage Ratio | -11.59 | -2.80 | 0.08 | -0.26 | -0.47 |
| Operating Cash Flow Coverage Ratio | -0.95 | -0.33 | 0.04 | -0.54 | -1.51 |
| Operating Cash Flow to Sales Ratio | -0.76 | -0.27 | 0.03 | -1.25 | -2.63 |
| Free Cash Flow Yield | -21.98% | -8.43% | -4.18% | -36.55% | -6.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.99 | -2.62 | -194.24 | -1.94 | -9.36 |
| Price-to-Sales (P/S) Ratio | 3.75 | 4.41 | 7.51 | 16.57 | 125.97 |
| Price-to-Book (P/B) Ratio | 1.32 | 1.70 | 2.11 | 1.83 | 9.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.55 | -11.86 | -23.92 | -2.74 | -15.41 |
| Price-to-Operating Cash Flow Ratio | -4.94 | -16.09 | 273.09 | -13.23 | -47.94 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | -0.00 | 1.96 | 0.15 | -0.01 |
| Enterprise Value Multiple | -6.51 | -3.96 | 27.54 | -2.27 | -48.25 |
| Enterprise Value | 10.65M | 19.62M | 33.43M | 27.18M | 116.17M |
| EV to EBITDA | -6.51 | -3.96 | 27.54 | -2.27 | -48.25 |
| EV to Sales | 4.35 | 5.20 | 8.00 | 18.25 | 125.55 |
| EV to Free Cash Flow | -5.28 | -13.98 | -25.48 | -3.01 | -15.36 |
| EV to Operating Cash Flow | -5.73 | -18.97 | 290.82 | -14.56 | -47.78 |
| Tangible Book Value Per Share | 0.04 | 0.06 | 0.10 | 0.10 | 0.11 |
| Shareholders’ Equity Per Share | 0.04 | 0.06 | 0.10 | 0.10 | 0.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 |
| Net Income Per Share | -0.02 | -0.04 | -0.00 | -0.10 | -0.11 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.20 | 1.07 | -0.81 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.47 | 0.45 | 0.47 | 3.73 | 2.84 |
| Stock-Based Compensation to Revenue | 0.06 | 0.18 | 0.17 | 2.62 | 1.23 |
| Income Quality | 0.61 | 0.16 | -0.71 | 0.15 | 0.20 |
Currency in CAD
